Skip to content

Smoking more harmful than HIV for people taking effective treatment, US study suggests

Dolutegravir regimen highly effective in clinical trial for women

Debbie Hagins of Chatham County Health Department, Savannah, Georgia, presents results of the ARIA study at ID Week 2016. Photo by Liz Highleyman, hivandhepatitis.com

Ibalizumab monoclonal antibody looks promising for people with drug-resistant HIV

Dr Jay Lalezari and Prof. Daniel Kuritzkes. Photo by Liz Highleyman, hivandhepatitis.com

Men with HIV and men on PrEP in Boston see large increase in sexually transmitted infections

Douglas Krakower at IDWeek 2016. Photo by Liz Highleyman, hivandhepatitis.com

Four days on, three days off HIV treatment controls viral load in French pilot study

Shutterstock.com

Do people living with HIV who have an undetectable viral load need to wear condoms?

Roy Gulick and Lisa Winston at IDWeek 2016. Photo by Liz Highleyman, hivandhepatitis.com

Electronic health records can help select candidates for HIV PrEP

Douglas Krakower at IDWeek 2016. Photo by Liz Highleyman, hivandhepatitis.com

Darunavir/ritonavir & lamivudine matches triple-drug therapy

Jose Arribas speaking at HIV Glasgow. Image credit: HIV Drug Therapy Glasgow 2016

Only a small proportion of gay men with HIV receive anal cancer screening

Mark Freedman at IDWeek 2016. Photo by Liz Highleyman, hivandhepatitis.com